MSD on PBS pricing fast track

By Megan Brodie 2 years ago | In Products, Reimbursement
  • 2 years ago

4 November 2024 MSD’s first-in-class small-molecule inhibitor WELIREG (belzutifan) is at the front of the…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads